ReviewOncology letters2025
Oral microbiota: Roles and treatment in radiation injury (Review).
Review in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While radiotherapy for malignant tumors increases the rate of local control for patients, it also inevitably causes damage to the surrounding normal tissues, resulting in different types and degrees of radiation injury (RI). RI has a significant negative impact on quality of life. However, there is no viable method for preventing and treating these complications. The oral microbiota plays a key role in the development of numerous categories of RI, such as radiation-induced brain injury, radiation-induced oral injury and radiation-induced lung injury. The aim of the present review is to clarify the potential mechanisms of RI and provide a comprehensive overview of the association between 10 distinct categories of RI and oral microbiota, thereby shedding light on novel clinical approaches for the prevention and treatment of RI based on modulating oral microbiota. This may open new avenues for targeted interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.